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Background: A history of a Hypertensive Disorder of Pregnancy (HDP) at least doubles
a woman’s risk of cardiovascular disease (CVD). The risk increases within 10 years after
HDP and continues for life, making long-term health after HDP of major public health
importance. Understanding knowledge gaps in health care professionals and women
regarding cardiovascular health after HDP is an important component in addressing
these risks.
Objectives: The primary aim was to examine what women and healthcare providers
(HCP) know about cardiovascular risks after HDP. The secondary aims were to identify
enablers and barriers to knowledge and action on knowledge.
Methods: A scoping review was conducted. This was a narrative synthesis, using
PRISMA-ScR guidelines, of English-language full text articles that included assessment
of knowledge of women, and/or HCP, on long term cardiovascular risk after HDP. The
databases Embase, Medline, Scopus, ProQuest, Cochrane, and PsycInfo were searched
from 01 January 2005 to 31 May 2019.
Results: Twelve studies were included, six addressing women’s knowledge, five
addressing HCP knowledge, and one addressing both. The studies included 402 women
and 1,215 HCP from seven countries. Regarding women’s knowledge, six of seven
studies found women had limited or no knowledge about the link between HDP and CVD.
Where women were aware of the link, the majority had sourced their own information,
rather than obtaining it through their HCP. In five of six studies, HCP also mostly
had limited knowledge about HDP-CVD links. Primary enablers for HCP acquisition of
knowledge and counseling were the availability and knowledge of guidelines. Where
comparisons between HCP groups were made, obstetricians had greater knowledge
than family physicians, internal medical specialists, or midwives.
Conclusion: There was a low level of knowledge amongst HCP and women about
increased CVD risk after HDP. Where women had higher levels of knowledge, the
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information was often obtained informally rather than from HCP. There were variations
in knowledge of HCP, with obstetricians generally more aware than other professions.
Further country and context-specific research on current status of women’s and HCP’s
knowledge is therefore necessary when creating educational strategies to address
knowledge gaps after HDP.
Keywords: knowledge, women, healthcare providers, preeclampsia, hypertension, cardiovascular risk
INTRODUCTION
Preeclampsia (PE) is a multi-system disorder unique to human
pregnancy characterized by hypertension and involvement of one
or more other organ systems and/or the fetus (1). Preeclampsia
is well-recognized as a major cause of poor pregnancy outcome.
It is one of the top three causes of maternal mortality and
severemorbidity in both high and low resource countries, leading
directly to over 50,000 maternal deaths globally per year (2). For
babies, up to one in five premature births occur following their
mothers having preeclamptic pregnancies (3).
In addition to the short-term impacts, long-term adverse
maternal health outcomes after preeclampsia and other
Hypertensive Disorders of Pregnancy (HDP) may be an even
greater burden of disease. Cardiovascular disease (CVD),
the leading cause of death in women globally (4), is 2–2.5
times higher for women who have experienced preeclampsia
at some stage in their life compared with those who had
normotensive (normal blood pressure) pregnancies (5–7). This
risk of premature death is present 8–20 years after the affected
pregnancy (6, 8, 9). Gestational Hypertension (GH), new-onset
hypertension without any other complications during pregnancy,
has little association with adverse pregnancy outcomes (1),
however is associated with long-term cardiovascular sequela
(7, 10). Together with essential hypertension (EH), which
indicates pre-existing increased cardiovascular risk, these HDP
conditions complicate∼10% of pregnancies (3).
Peak cardiovascular health organizations, such as the
American Heart Foundation, now recommend health care
providers ask women about their HDP history when assessing
their cardiovascular health and risk factors. The International
Society for the Study of Hypertension in Pregnancy (ISSHP)
recommendations (5) address the postpartum management of
HDP and recommend a review at 3 months to ensure screening
tests are within normal range or alternatively ensure appropriate
referral occurs. ISSHP also recommends informing women of
their long-term CVD risk, adoption of a healthy lifestyle with
maintenance of an ideal weight and regular aerobic exercise,
and regular follow-up with a general practitioner to monitor
blood pressure and periodic measurement of fasting lipids and
blood sugar.
Despite these recommendations, clinicians may not be aware
of the association between HDP and CVD, suggesting that
women are not given appropriate information about health after
HDP (11–16). Several studies conclude that both health care
providers and women should be provided with information
regarding the link between HDP and later CVD (17–19).
Therefore, the primary aim of this paper was to undertake a
scoping review to examine what women and healthcare providers
(HCP) know about cardiovascular risks after HDP. Secondary
aims were to identify the aspects of care that can be seen as
enablers and barriers to knowledge and action on knowledge.
METHODS
A scoping review of published literature on knowledge of women
and/or health care providers about CVD risk after preeclampsia
or gestational hypertension was undertaken. Scoping reviews
follow a systematic approach to identify main concepts, evidence,
and knowledge gaps on a specific topic (20). This methodology
was appropriate given our interest in the broad topic of
knowledge on health after HDP and the likely heterogeneous
nature of the body of literature. This scoping review adheres to
PRISMA-ScR guidelines (20) (Appendix 1) and the CASP (21)
qualitative checklist was also used to assess quality in the of
included qualitative literature (Appendix 2). Narrative synthesis
was applied to analyze the included literature.
We searched multiple Databases including Embase, Medline,
Scopus, ProQuest, Cochrane, and PsycInfo. The year of
publication was limited to 1st January 2005 to 31st May
2019. Key words descriptors, Medical Subject Headings
as well as MeSH terms were (but not limited to): “Health
Knowledge, Attitudes, Practice,” “Education∗,” “Communication
Barriers,” “Risk perception,” “Enablers,” “Knowledge,”
“Knowledge gap,” “Knowledge sharing,” “Pre-eclampsia,”
“gestational hypertension,” “Hypertension, Pregnancy-Induced,”
“future cardiovascular disease,” “long-term cardiovascular
risk” (Appendix 3).
Key words were developed and separated into search
categories. One was knowledge/education/risk perception,
another was PE/GH/HDP and a third was long-term CVD
risk. Database searches were accompanied by hand searching
reference lists and citations of all included studies to identify any
additional, relevant studies.
Papers were included (Supplementary Table 1) if they
were original research addressing knowledge assessments,
communication and awareness of long-term increased CVD
risk after PE (including HELLP and eclampsia) or GH, full-
text, available in English and if published during the selected
timeframe. The date limit was applied as most initial cohort
studies showing increased risk of CVD after preeclampsia were
not published until the early 2000s, and the first risk meta-
analysis was not published until 2007 (22). Studies of any
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methodology (qualitative/quantitative/mixed methods), sample
size and type were eligible for inclusion.
Papers were excluded (Supplementary Table 1) if they were
a conference or research abstract only, a review article without
novel research, or items (e.g., study protocol or trial registration)
that pertained to planned or in-progress research without
published results. Where abstracts matched our search criteria
and topic but with no details on study method and results and
no full-text associated publications were found, authors were
contacted for further details. However, this did not yield further
inclusions by the cut-off of 31st May 2019.
Research that concerned chronic hypertension only (without
superimposed PE) was excluded, as chronic hypertension is
recognized by healthcare professionals as conveying increased
CVD risk. Additionally, papers with focus only on the
application of lifestyle recommendations to reduce the CVD
risk after experiencing a pregnancy with hypertensive disease
were excluded.
All articles were independently reviewed for inclusion by
two reviewers who read the title, abstract, and full text.
Discussion between the two reviewers resolved discrepancies.
After summarizing the included papers, the papers were split into
two categories: women’s knowledge, and HCP’s knowledge.
The Critical Appraisal Skills Programme (CASP) (21) tool was
used to assess quality of the included literature. Although this is a
tool designed to assist in systematic review inclusions, this quality
appraisal tool was helpful in the systematic approach to enquire
and reason about the studies eligible within the boundaries of the
inclusion/exclusion criteria. The CASP checklist addresses three
areas when appraising literature to be included in a review, these
are validity, results and clinical relevance.
RESULTS
Of 1,467 identified articles, 12 studies met inclusion criteria
(Supplementary Figure 1). Supplementary Table 2 summarizes
the characteristics of the studies included.
Out of the 12 studies, six addressed women’s knowledge
(11, 13–16, 23), five addressed HCP’s knowledge (24–28) and
one addressed both women and HCP (12). The studies include
eight quantitative (surveys, chart reviews) (15, 16, 23–28) and
four qualitative studies (11–14) (focus group, group interview,
semi-structured interviews). Of the qualitative studies, most were
assessed as moderate to high quality on CASP criteria and
details are itemized in Appendix 2. In total, the studies collected
information from 402 women to 1,215 HCP.
Five studies were conducted in the United States of America
(USA) (13–15, 27, 28) two from Canada (12, 26) one each from
Australia (23), Germany (25), Nigeria (24), Portugal (16), and the
United Kingdom (UK) (29).
The included studies displayed various levels of focus on
knowledge assessment of CVD after HDP. Eleven conducted
surveys or interviews exploring the women’s or HCP’s knowledge
specifically and more extensively. One study’s focus was on
exploring general follow up of women with a history of PE
and women’s knowledge of CVD risk factors in general but did
include a single question regarding women’s knowledge on the
link between PE and future CVD (16).
Women’s Knowledge
Seven (including the study addressing both women and HCP)
studies addressed women’s knowledge (11–16, 23). Three were
quantitative (15, 16, 23) and four were qualitative studies (11–
14). Six studies focused on the exploration of women’s knowledge
(11–15, 26) while one (within a study with a different main focus)
included a question about whether counseling of HDP link to
CVD had occurred (16).
Six out of the seven studies found that women had limited
or no knowledge about the link between HDP and CVD. In
the USA, Seely et al. (13) found that in 20 women after PE, the
“majority” were not aware of their HDP CVD risks. In another
study in the USA, 10 of the 14 participating women (71%) were
unaware of the link between PE and CVD (14). A survey of 78
women in Portugal found that nearly 70% were not counseled
on the link between PE and CVD (16). There was some evidence
that women’s knowledge of future CVD risk perception differed
according to the type of severity of their HDP. A study of 146
women in the USA (of which 52% were without severe features,
28% PE had severe features such as HELLP and Eclampsia and
20% had Chronic Hypertension alone) found that CVD risk
awareness was higher in those with severe PE (65%) and chronic
hypertension (75%) than those with PE without severe features
(43%) (13, 15). In Canada, Hird et al. (12) reported that the
five women in their study were either not at all informed or
partially informed. When informed this was limited to two out
of five women finding out about potential recurrence of PE in a
subsequent pregnancy. Four of the five women were not advised
to have any follow-up blood tests. Only one out of the five
women was advised about her CVD risk. In the UK, Brown et al
(11) found that five of their 12 participants could not recall the
HDP-CVD risk being raised with their HCP. Of those who were
counseled of their risk, it was found that especially those women
without a family history of CVD did not perceive the risk to apply
to them.
The one exception was the Australian study by Hutchesson
et al. (23), where close to two thirds of 127 women with a recent
history of PE (≤ 2 years post PE) had higher knowledge about
certain aspects of future CVD risk (96% answered “true” for
future risk of hypertension and 66% answered “true” for future
risk of stroke).
Women’s Knowledge in the Early Postpartum Period
vs. Later
There were conflicting findings regarding whether women in
the first few years after HDP had higher knowledge about
future CVD risk than those 5 years or more post-pregnancy. In
Australia, Hutchesson et al. found 67% of women with recent PE
(≤2 years) were aware of future CVD risk. However, in the USA a
focus group study of women who had preeclampsia<5 years ago,
the majority of the 20 women did not know of their future CVD
risk until they attended the focus groups (13). There were similar
findings in another focus group study of 14 women (14) where
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most (10/14) of the women were unaware of the link between PE
and future CVD.
Sources of Knowledge, Enablers, and Barriers to
Knowledge Acquisition in Women
Three of the seven studies explored sources of knowledge
acquisition by the women (12, 14, 23). These showed that women
in general wanted information on their HDP and to understand
more about its link to future CVD. For example, in Brown et al.
(29), all 12 women interviewed with a history of PE wanted
to receive more information on PE and future implications on
health. Enablers and barriers to women’s knowledge acquisition
were also addressed by most of the studies.
Of the seven studies that enquired about women’s perceptions
of being given information, major themes were that women
did not receive information, or felt they received insufficient
information, from their healthcare practitioners about risks after
HDP. For those who were aware of long-term risks prior to
being surveyed or interviewed, this knowledge had often been
self-acquired. Hutchesson et al. (23) undertook a cross-sectional
survey with women who had a recent preeclampsia diagnosis
to examine their knowledge about whether they were at greater
risk of developing a list of health complications. The participants
(n = 127) displayed high awareness about being at greater
risk of developing hypertension later in life (98%) and being
more susceptible to stroke and CVD (67%). However, 60% of
the “aware” participants reported that they gained knowledge
by doing their own research, while only 25% heard about
their long-term risk from their obstetrician, about 13% from
their general practitioner and 6% from their midwife. Despite
most participants (about 95%) having had their blood pressure
measured, a lower proportion reported serum cholesterol and/or
glucose screening (about 41%), and fewer had received advice on
various lifestyle risk factors (ranging from 2% for smoking and
about 30% for weight management, exercise and healthy eating).
The one study addressing both women’s andHCP’s knowledge
assessed how relationships between risk, pregnancy, and women’s
health are understood and acted upon. Five women were
interviewed, and they reported being either minimally or not
informed around diagnosis about long-term CVD risk after PE.
Recurrence of PE in a subsequent pregnancy was addressed
with two of the five interviewees. Only one was tested and
counseled at 6 weeks postpartum. Women were unsure whether
their pregnancy history was transmitted to their family physician.
Women did not always trust the skills and knowledge base as well
as the decisions made by their care givers. Finally, participants
had made extensive efforts to source information relating to their
condition from places like the internet, online discussion boards,
magazines, and even television series (12).
One of the qualitative studies in the UK showed that women
with a family history of CVD disease had greater awareness of
future CVD risk (29). Of the 12 women interviewed, seven had
family history of CVD (29). Women without traditional risk
factors found it hard to envisage themselves as being at risk
and did not see the relevance of such information. The authors
noted timing of discussions as an important element to consider
when communicating about postpartum risk, taking into account
situational factors of new motherhood, and when women are
ready to consider their own health as well as their baby’s, to
engage successfully with this group of women (29). A study
conducted in Portugal of 78 women with either history of PE or
CH and superimposed PE showed that addressing of risk after PE
by HCP predominantly did not happen (54 no vs. 24 yes) (16).
Healthcare Provider’s Knowledge
The studies about health providers’ knowledge varied in the
screening questions and detail of knowledge inquiry. Six
studies addressed HCP’s knowledge (including the study which
addressed both groups) (12, 24–28). The studies assessed
knowledge with varying depth, therefore the results display
different aspects of knowledge.
A Canadian study with 554 participants (obstetrician/
gynecologist, midwives, and family physicians) (26) showed
that almost two-thirds (64%) knew that women with a history
of gestational hypertension had a higher risk of developing
hypertension in the future. About one-half of the clinicians were
aware that women with a history of PE were at higher risk
than nulliparous women to develop hypertension in the future.
The study did not compare knowledge between the different
HCP groups.
In one of the USA studies (28), participants were asked about
their typical counseling for CVD risk reduction. This showed that
of 161 participants (118 internists/internal medicine physicians,
53 obstetricians) 95% of internists and 70% of obstetricians
reported providing general CVD risk reduction counseling.
When asked about knowledge of future cardiovascular risks
in women with preeclampsia, the majority in both groups
were incorrect or unsure about the risk of several future
comorbidities associated with a history of PE. With the
exception of risk of future hypertension, where only 6%
internists and 17% of obstetricians answered incorrectly, the
comorbidities that were surveyed yielded a significant knowledge
gap. The other risks surveyed were future risk of ischemic
heart disease (56% internists and 23% obstetricians answered
incorrect/unsure), stroke (48% internists and 38% obstetricians
answered incorrect/unsure), and a shorter life expectancy which
displayed the highest percentage of incorrect/unsure answers
(79% internists and 77% obstetricians). Only 5% of internists and
42% of obstetricians asked about PE as part of taking a woman’s
medical history. Of the doctors asking about a PE history,
only a small group (9% of internists and 38% of obstetricians)
provided counseling to women at risk. The findings suggested
that clinicians are not aware of the association between adverse
pregnancy outcomes such HDP and CVD (28).
Wilkins-Haug et al. (27) undertook an anonymous survey
in the USA. The survey was case-based, had 124 participants
and explored obstetrician/gynecologist vs. internists’ recognition
of long-term CVD risk after preeclampsia. One aspect of the
survey was to assess the participants’ understanding of how
pregnancy history may influence long-term cardiovascular risk,
where information was collected through a combination of
direct query, multiple choice responses, case-based questions,
and branch logic. The second aspect assessed their general
knowledge of CVD risk. Overall, about 28 and 15% of internists
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and obstetricians, respectively, indicated they would not obtain a
pregnancy history when specifically assessing a patient’s history
for cardiovascular risk. When history of PE was obtained,
internists were more likely to order fasting glucose test than
gynecologists (48% vs. 21%).
In Germany, a survey about knowledge of the association
between preeclampsia and long-term risks of CVD was
distributed to a random sample of 500 obstetrician-gynecologists
with 121 participating. Overall, the doctors with better
knowledge of existing guidelines had better understanding of
risks and were more likely to offer counseling to women with
a history of PE. More specifically, 87% of doctors knew of
the association between PE and future hypertension, whilst
79% knew about the association with stroke risk. Although the
majority of the respondents were aware of the increased CVD
risk post preeclampsia, the awareness of existing guidelines on
long term follow up care and counseling of affected women
remained deficient. Only 45% of participants were aware of
these guidelines, however knowledge was higher amongst these
participants (25).
The only study in a low to middle income country (LMIC)
was undertaken by Adekanle et al. (24) in south western Nigeria.
A survey was distributed to 146 healthcare professionals as
part of a workshop at a teaching hospital. The majority (87%)
were knowledgeable about future hypertension risk after PE and
about ischemic heart disease (63%), stroke (69%), and kidney
disease risk (73%). Forty-six percent counseled on CVD risk
after hypertensive disease. The doctors had better knowledge
(78% overall) than both nurses (58%) and community healthcare
workers (54%). However, the majority (64%) were not aware that
a shorter life expectancy is linked with preeclampsia, while only
38 (26%) asked about preeclampsia on routine visits and 46%
counseled on cardiovascular risk.
Enablers and Barriers to Knowledge Acquisition for
Healthcare Providers
A Canadian study (26) identified weaknesses in knowledge
base and communication amongst the maternity care providers
and community health care (family physicians). There was a
significant discrepancy when addressing the communication
between the hospital to community handover after HDP. Of
the participating maternity care providers, 83% stated that they
informed the family physician with regards to the woman’s
history after HDP. However, only 58% of the participating family
physicians stated that they received HDP information about the
women transitioning back into the community. Furthermore,
only 12% of family physicians stated that they were made aware
that women post HDP are at increased risk of CVD, despite
41% of maternity HCP claiming that this happened. This study
suggests that effective identification and follow-up of women
with HDP is not occurring.
A follow up Canadian study assessed whether HCP shared
information with women about their increased CVD risk (12).
In this study of 8 healthcare practitioners, three of the eight
did not inform women of increased risk more than 50% of
the time. Interviews were undertaken to explore participants’
perceptions of and attitudes toward the relationship between
PE and CVD risk. Structural, practical, and ideological barriers
were shown to impede knowledge sharing between health
care providers and women about the relationship between
preeclampsia and CVD risk (12). Patient electronic records were
not consistently available to all HCP, hence the community health
care providers are reliant on written records transferred to them.
One obstetrician in Hird et al.’s study (12) relied on assumed
knowledge of midwives and family physicians to link PE to long-
term CVD risk. HCP reported filtering what they said and when
about a certain situation. Some were cautious about the timing
(e.g., in high stress situation) and others felt that if the women
did not ask they would probably not want to know and hence the
HCP would not address the topic.
Three of the six studies mentioned guidelines (12, 24, 25). In
Adekanle et al. (24) it is unclear which guideline participants
are asked about. Their discussion refers to a national guideline,
however declares that PE guidelines are institution based. Only
16% of participants were aware of a guideline, the authors suggest
this number may reflect the medical practitioners as there was
a smaller number of them. Heidrich et al. (25) asked about
awareness of current national guidelines which comment on
follow up of PE and future CVD risk management. Overall
only 45% knew about these guidelines with significantly more
knowledge in the group with guideline awareness. The group
with guideline knowledge counseled women more frequently
about long term risks, more frequently assessed blood pressure,
had better knowledge of the link between HDP and CVD
and screened for family history of PE more frequently. The
third study (12) found that the absence of clinical practice
guidelines had a possible effect on the postpartum management
of PE and CVD risks. The current guidelines’ focus was
more on the diagnosis and the intrapartum management
of HDP.
DISCUSSION
This scoping review found that, in most studies, women’s and
HCP’s knowledge about the increased risk of CVD after HPD
was low. The various studies explored differing aspects of
knowledge. Some studies included one question about knowledge
of the association of HDP and CVD, whereas other studies
used further questions to differentiate amongst the various
aspects of knowledge on this topic. Three studies used the
term “risk perception” which showed a distinction between
basic factual knowledge vs. how a woman at risk may perceive
her own risk as true or not true. Issues with communication
between different HCP (between hospital and community) as
well as between HCP and women was identified, particularly
when asking about pregnancy history when CVD risk assessing,
transferring pregnancy history and risk factors to community
health care providers, and counseling women on the long-term
CVD risk. Due to the diversity in explored aspects of knowledge
within the included studies it is difficult to compare and contrast
the studies themselves. A common ground however is found
in their discussion of enablers and barriers to the acquisition
of knowledge.
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Enablers to Acquisition of and Action on Knowledge
There were a number of enabling features for knowledge
acquisition. The internet and access to a variety of information
via online communities and networks appeared to be an enabler
for women. Where women displayed reasonably high aspects
of knowledge, it was found that had sourced this information
by conducting their own research (12, 23). Women felt it was
beneficial to receive information on how this risk could be
reduced (29).
Clarification on the extent to which a history of preeclampsia
and gestational hypertension are an independent factor for
future CVD are considered helpful in the provision of effective
communication (29). Interestingly, risk perception of HDP
recurrence and future CVD due to HDP was higher in women
who had a family history of CVD and/or PE with severe features
(15, 29), further indicating that many other HDP affected women
do not identify with the increased risk. They may not be aware
that they could be affected in the future and are less likely to
seek information as a result. Poor self-reporting of a PE and GH
history may also accentuate the issue (30–33).
Some women felt that having access to other women who
have had a similar pregnancy experience with HDP may have
been a supportive move toward risk reducing lifestyle changes.
Access to community of women who have experienced HDP or
similar support groups may be helpful in feeling less isolated,
more informed and supported (13, 14, 29). The thought of
being able to support other women in similar situations was
a motivator. The suggestion to have privacy maintained in
this online community and a moderator who could validate
medical information exchanged as well as keep the community’s
communication positive. In other areas of women’s healthcare,
including breastfeeding and polycystic ovarian syndrome, online
community groups have been effective (34, 35) for women’s
emotional support and empowerment, so could be explored
further for post-HDP women.
Online tracking of weight and blood pressure was deemed
to be helpful in the application of knowledge with regards to
lifestyle changes. Having support from family members when
implementing lifestyle changes was deemed important and their
family also benefiting from the healthy changes was a further
motivator (14). Women felt that a reminder by their health
care providers to follow up after HDP was needed to bring the
mother’s health back into mind after having given birth and
transitioning to parenthood (29).
Barriers to Acquisition of and Action on Knowledge
A lack of knowledge from their health care provider on the link
between HDP and CVD was a barrier to women, as well as
their poor insight into or lack of action toward risk reducing
lifestyle changes. The lack of knowledge about the link is also
a barrier for women to then act on possible modifiable CVD
risks or to simply gain insight into and understanding of the
HDP they experienced. Barriers to action for women were
predominantly related to family and caregiving responsibilities,
lack of knowledge, lack of appropriate, and timely follow up as
well as remembering what type of follow up and monitoring
they needed, as well as poor recovery postpartum (13, 29).
The amount and type of information given at any particular
healthcare encounter was considered to be a barrier (12).
From the HCP perspective, HCP felt some information
needed to be repeated over multiple visits to be truly understood,
and that limited consultation time required them to prioritize the
type of information shared with women. Some only responded to
questions raised by the women and withheld other information.
In turn, women were not confident they are being given all
the information they need postpartum to manage their risk
(12). Transition from hospital-based obstetric care to primary
community-based care was also a barrier for women (and a
system level barrier) as was lack of health insurance (in the
USA) (13).
Healthcare Providers
Where comparisons between HCP groups were made,
obstetricians had a higher level of knowledge than family
physicians, internal medical specialists, midwives or community
health workers (24, 26, 28). Knowledge and application into
practice was demonstrated when guidelines were available, and
their existence was known (25).
There was only one study conducted in a LMIC (24). In
this setting (Nigeria), knowledge was higher amongst doctors
compared with “lower cadre” health workers (examples cited
in the included paper include associate nurses, community
health workers). Although different contextually, this statement
could be applicable to high income countries where community-
based health care providers (such as general practitioners/family
physicians/community nurses) are close to the community.
Enablers to Acquisition of and Action on Knowledge
Implementation and knowledge of guidelines may provide an
enabling environment for better knowledge and application of
this knowledge (25, 28). An example of positive influence of the
implementation of guidelines can be found in the Netherlands
(36), where an increase in counseling following preeclampsia
occurred. This is likely to reflect an increase in education of
gynecologists over time regarding cardiovascular risk, resulting
in confidence addressing these concerns with the women in
their care.
The type of specialty training in theHCP domain was a further
enabler. When knowledge amongst professions was compared,
obstetricians were more knowledgeable than family physicians
and midwives for example (24, 27, 28). This may be linked to
the training, scope of practice as well as exposure to women with
HDP that this medical specialty has. More generally, although
potentially linked to specialty training, Wilkins-Haug et al. (27)
found that when there was better overall knowledge of CVD risk
factors and screening knowledge, this was associated with greater
knowledge of association of PE with later life CVD.
Barriers to Acquisition of and Action on Knowledge
Poor communication between hospital and community HCP
was mentioned in almost all HCP papers (13, 24, 26, 28). In
areas where knowledge was high this did not translate into
action-taking on the reduction of long-term risk factors (24).
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There were also a number of examples of withholding or
not sharing information from women during CVD counseling
or post HDP counseling (26, 28). Even when providers
know about the association of PE with later CVD they did
not apply this knowledge when counseling women. Further
information on what a history of HDP means in terms of
increased future risk and follow-up needed was perceived as
not frequently shared by maternity specialists (26). Here too the
gap between the information sharing by maternity HCP and
information reception by community HCP was significant (26),
with participants’ answers possibly reflecting the intention of
communication rather thanwhat actually occurs in daily practice.
Studies comparing latest clinical guidelines in different
countries highlight the variations in clinical recommendations
(most likely due to lack of high-level evidence base for what is
effective post-HDP follow-up) and lack of cost effective follow
up. Some authors suggested further studies take place in order
to inform practice guidelines and optimize prevention strategies
(37). These include adjustment of general CVD guidelines to
include taking a pregnancy history (38–40) and associating HDP
with the increased risk of developing CVD.
A large amount of research exploring various aspects of
women’s increased CVD risk with a history of HDP have
suggested that education as well as addressing modifiable risk
factors could be targeted for improving the short- and long-
term sequela for women (8, 17). The literature shows that
poor pregnancy history taking is common. Recent population
research has found women are less likely than men to have their
cardiovascular (CVD) risks (not including preeclampsia history)
fully assessed, and less often have risks appropriately managed
when they are assessed (41). The gap may occur due to a number
of potential barriers. Firstly, at individual and social levels,
physicians may not be aware or familiar with existing guidelines
on best practice in this matter. Secondly, physicians and women
may have the old misconception of CVD being a man’s disease.
Furthermore, the misconception of senior physicians may have
been passed on to the younger generation of physicians. In
addition to financial and time and resource constraints, it is likely
that women have been disadvantaged in receiving appropriate
CVD risk factor assessment. When assessments do happen,
women also are less likely than men to have their risks managed
appropriately. Therefore, an increased rate of assessment and
management of CVD risks are needed are needed in women
generally, over and above specific management after HDP (41).
Considering pregnancy history when assessing a woman’s
CVD risk may assist in targeted efforts to initiate risk-reduction
strategies in women with a history of pregnancy complications
and improve communication between women and health care
providers as well as communication between maternity and
community providers. This may help decrease the burden of
CVD in women (40, 42) and minimize the need for women
having to rely mainly on exploring resources online to educate
themselves (23).
Implications for Practice
Overall, there appears to be a knowledge gap in women and HCP
on the association of HDP and risk of CVD. This gap could
be narrowed and the information about this topic needs to be
distributed in a suitable, accessible and targeted way.
The study that reflected reasonably high knowledge levels
and counseling of women reasoned that the participants were
aware of the existence of guidelines on the topic and showed
application of these in practice (25). Guidelines are available
(5) however their existence alone may prove to be insufficient.
A potential education campaign of guideline awareness is one
of the solutions, to encourage implementation of guidelines
into practice.
Knowledge of HDP link to future CVD in both the HCP
and women would be optimal in order to make progressive
adjustments to potentially reduce the risk of future disease.
Studies conducting research on lifestyle adjustments for women
with a history of HDP have already been published in some
countries. This shows attempts to reduce risk by applying the
knowledge HCP and women have.
A specific follow up clinic may be an effective method of
prevention of future risk for women (43, 44) as knowledge
alone about risk may not translate into motivation or changes to
lifestyle in order to reduce risk (45). There are early benefits of
counseling about lifestyle modifications in order to prevent CVD
in women with recent preeclampsia. Channeling women into
appropriate health centers once pregnancy care is completedmay
be an enabling approach (43, 44). Careful pregnancy screening
and appropriate escalation to the right health care provider,
women’s risk profile can be identified and addressed. Appropriate
referral offers opportunity to determine effective treatments
that can prevent the progression of hypertensive disorders in
pregnancy and in turn reduce future CVD (43).
The Gap Identified in the Literature
This review has identified some gaps in the literature. The lack
of evidence and hence of clear guidance on how to provide
information to women who have experienced HDP identifies
one of these gaps. More specific aspects of knowledge on the
topic need to be assessed in women and HCP such as more
specific knowledge of individual risk factors. Furthermore, higher
numbers of women and HCP in a variety of countries and
healthcare settings could be assessed and contribute to a more
in-depth insight into knowledge levels and also on possible
targeted knowledge enhancing strategies. Despite having gained
insight into some of the enablers to knowledge acquisition and
application, little evidence has been collected addressing what
form education should take.
Strengths and Limitations
Strengths of the review include the comprehensive search strategy
and scoping review by two independent reviewers according to
PRISMA-ScR criteria. It provides an up-to-date evidence-base of
the literature on the topic of women’s and HCP’s knowledge of
cardiovascular health after hypertensive pregnancy. Our scoping
review looked at both perspectives (women and HCP) and
contextualized these findings amongst a larger context of CVD
screening and prevention, enablers and barriers as well as from a
primary health perspective.
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The included literature is limited to English language. The
methods of the research we included are diverse and different
aspects of knowledge were examined amongst different HCP.
Women’s medical conditions examined also slightly varied from
one paper to another. Having included international literature,
cultural health context with access to healthcare are different, this
makes the findings more difficult to compare and contextualize.
Knowledge is contextual, and knowledge of risk factors and risk
reducing behavior does not imply action on this knowledge.
This aspect is hard to measure and by participation alone,
this may already show a sign of bias to being receptive to
knowledge and possibly motivated to make lifestyle changes.
When planning knowledge transmission and action on health
after HDP, it is important to consider the local context. This
applies to the country’s available health services, workforce, and
scope of follow-up care postpartum. Despite the different settings
of the included studies, there were several common themes
around knowledge gaps, barriers, and enablers of acquisition
of knowledge that were found in this review, including low
knowledge among women and HCP of CVD after HDP, lack of
communication of knowledge by HCP with higher knowledge
(usually obstetricians) to HCP colleagues and women, and
women’s use of informal sources to gain knowledge. This suggests
some generalizability regardless of context.
CONCLUSION
In general, there is a lack of knowledge amongst HCP and women
regarding CVD risks after HDP Where women had higher levels
of knowledge, the information was often obtained informally
rather than from HCP. Obstetricians were generally more aware
than other professions of the HDP-CVD link, however did
not necessarily communicate this knowledge to either women
or other HCP. Awareness of risk factors may provide, in
conjunction with further research on effective risk reduction
methods, a unique opportunity to plan future screening and
preventative health recommendations by primary health care
providers, which currently appears to be insufficient in women
with a history of HDP. Further country and context-specific
research on current status of women’s and HCP’s knowledge
is therefore necessary when creating educational strategies to
address knowledge gaps after HDP.
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